Accounts Administrator

TITLE: Accounts Administrator
LOCATION: Cambridge, UK
SALARY: Competitive salary and benefits package, relative to qualifications and experience

Overview
Amphista Therapeutics is a fast-growing Cambridge-based biotech and the leading European Targeted Protein Degradation (TPD) company. Our unique scientific approach to TPD, one of the hottest areas in modern drug discovery, gives us a range of advantages over other therapeutic strategies.

We have completed an oversubscribed $53M funding round to allow us to progress our portfolio of projects and greatly strengthen the development of our underlying scientific platform. We were delighted to recently announce two separate collaboration deals with Bristol Myers Squibb and Merck Healthcare which will allow us to grow and advance our therapeutic portfolio even faster, utilising our unique technology.

Initially founded from the laboratory of Professor Alessio Ciulli (University of Dundee) our team comprises both academic and drug discovery pioneers of the TPD field and a growing R&D team focused on advancing a portfolio of medicines to the clinic using our proprietary next generation TPD technologies.

This is an exciting opportunity to join one of the fastest-growing UK-based drug discovery biotech’s and be part of a dynamic, adventurous and fast-moving team of experienced drug discoverers and TPD experts in a brand-new research facility.

We’re now growing the team further and have an opportunity for an Accounts Administrator to join us to be part of our incredible journey.

The Accounts Administrator will report directly to the Financial Controller – Trevor Bennington.

Roles and responsibilities include:

• Maintaining the Purchase Ledger to include data entry, supplier statement and purchase report reconciliations.
• Produce monthly payroll for c.60 employees
• Dealing with supplier queries
• Process employee out of pocket business expenses and company credit card transactions
• Assist Financial Controller with month and year end accounts preparation, as well as VAT and Office for National Statistics submissions.
• Assist Management Accountant with business stakeholder KPI’s and financial performance insights.
• Prepare bank reconciliations.
• Assist with implementing improved processes and internal controls.
• There will also be a variety of administration duties such as maintaining the Accounts filing system and archiving documents.

Essential requirements:

• Previous experience working in purchase ledger.
• Accuracy is essential in the role, and you should be proficient in MS Word, Excel, and Outlook
• Ability to work under pressure, quick to learn, well organised and conduct themselves in a polite and professional manner.

Desirable:

• Experience of Xero desirable (or other accounting systems)
• System and process improvement experience
• Biotech or pharma sector experience

What’s on offer

Competitive salary and benefits package including share options and discretionary bonus.

Hybrid working

More about Amphista

Amphista’s approaches use completely novel mechanisms to build on all the advantages of TPD while directly addressing the emerging limitations of existing TPD strategies to expand the utility of the field. In particular, we have shown our approach has the potential to be superior to all other TPD approaches (PROTACs, molecular glues etc) through our unique novel mechanisms giving expanded scope, improved druglike properties and reduced tumour resistance potential. We have a range of projects in the discovery phase, initially focused on oncology with potential to expand into other therapy areas including CNS disease & immunology. Amphista R&D is based Cambridge, UK from where we also work with a wide range of global collaborators and CROs.

The Amphista team contains a wide range of experienced drug discovery experts across both biology and chemistry disciplines, creating the ideal learning environment to advance your scientific career development quickly. This is an exciting opportunity to join a fast growing and dynamic company operating at the cutting edge of protein degradation-based drug discovery to develop first-in-class medicines to treat cancer and other areas of high unmet medical need.